Patent · US Active

Chemical compounds

US9018381B2 · kind B2 · utility

26Cited by
8References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2011
Grant dateApr 28, 2015
Priority date
Expiry dateDec 18, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/650952
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula (I):and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-XL activities and may be used for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.